Related Experiment Video
Updated: Mar 17, 2026

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
14.6K
Respiratory Failure and Intensive Care Support Following Bone Marrow Transplantation.
B J Hennessy1, N Dowd2, G M Crotty1
1a Department of Hematology , St. James's Hospital , Dublin 8, Ireland.
Hematology (Amsterdam, Netherlands)
|July 15, 2016
Summary
Bone marrow transplant recipients requiring intensive care unit (ICU) admission, especially for respiratory failure, have a poor prognosis. Early bronchoscopy diagnosis did not improve survival rates in this high-risk patient group.
Area of Science:
- Hematology
- Critical Care Medicine
- Pulmonology
Background:
- Allogeneic bone marrow transplantation (BMT) recipients often face life-threatening complications necessitating intensive care unit (ICU) admission.
- The prognosis for BMT recipients requiring ICU care is generally poor, particularly when complicated by respiratory failure.
Purpose of the Study:
- To retrospectively analyze the outcomes of BMT patients admitted to the ICU.
- To evaluate the impact of early diagnostic interventions, such as bronchoscopy, on survival rates in this population.
Main Methods:
- Retrospective review of 25 BMT patients admitted to the ICU between January 1989 and May 1997.
- Analysis of reasons for ICU admission, interventions performed (ventilation, bronchoscopy, bronchoalveolar lavage (BAL), transbronchial biopsies (TBB)), and survival outcomes.
Main Results:
- Respiratory failure was the most common reason for ICU admission among BMT recipients.
- All 25 patients required mechanical ventilation, with only two surviving.
- Early bronchoscopy with BAL and TBB yielded diagnoses in 50% of investigated patients, but did not translate to improved survival despite treatment adjustments.
Conclusions:
- Severe respiratory failure post-BMT remains a critical condition with a poor prognosis, even with intensive support and early diagnostic procedures.
- While early bronchoscopy can provide a diagnosis in half of the cases, it has not demonstrated a survival advantage in this study cohort.
More Related Videos
Related Concept Videos
Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Acute Respiratory Failure-V
617
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
617
Tissue Transplantation
1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-II
1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K

